The University of Chicago Header Logo

Connection

John Fung to Mice, Inbred C57BL

This is a "connection" page, showing publications John Fung has written about Mice, Inbred C57BL.
Connection Strength

0.696
  1. Induced pluripotent stem cells-derived myeloid-derived suppressor cells regulate the CD8+ T cell response. Stem Cell Res. 2018 05; 29:32-41.
    View in: PubMed
    Score: 0.025
  2. C-C Chemokine Receptor Type 2-Dependent Migration of Myeloid-Derived Suppressor Cells in Protection of Islet Transplants. Transplantation. 2017 08; 101(8):1793-1800.
    View in: PubMed
    Score: 0.024
  3. Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. Liver Transpl Surg. 1997 Mar; 3(2):118-29.
    View in: PubMed
    Score: 0.023
  4. Painting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage. Biomaterials. 2016 09; 102:209-19.
    View in: PubMed
    Score: 0.022
  5. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Immunology. 1996 May; 88(1):124-9.
    View in: PubMed
    Score: 0.022
  6. Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death-Ligand 1. J Immunol. 2016 Feb 15; 196(4):1617-25.
    View in: PubMed
    Score: 0.021
  7. Complement anaphylatoxin receptors C3aR and C5aR are required in the pathogenesis of experimental autoimmune uveitis. J Leukoc Biol. 2016 Mar; 99(3):447-54.
    View in: PubMed
    Score: 0.021
  8. Hepatic Stellate Cells Inhibit T Cells through Active TGF-ß1 from a Cell Surface-Bound Latent TGF-ß1/GARP Complex. J Immunol. 2015 Sep 15; 195(6):2648-56.
    View in: PubMed
    Score: 0.021
  9. Rejection triggers liver transplant tolerance: Involvement of mesenchyme-mediated immune control mechanisms in mice. Hepatology. 2015 Sep; 62(3):915-31.
    View in: PubMed
    Score: 0.021
  10. Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells. Transplant Proc. 1995 Feb; 27(1):509-10.
    View in: PubMed
    Score: 0.020
  11. The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion. Transplant Proc. 1995 Feb; 27(1):511-2.
    View in: PubMed
    Score: 0.020
  12. Cotransplantation with myeloid-derived suppressor cells protects cell transplants: a crucial role of inducible nitric oxide synthase. Transplantation. 2014 Apr 15; 97(7):740-7.
    View in: PubMed
    Score: 0.019
  13. Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences. Transplant Proc. 1993 Feb; 25(1 Pt 1):362-3.
    View in: PubMed
    Score: 0.017
  14. The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood. 2013 Mar 07; 121(10):1760-8.
    View in: PubMed
    Score: 0.017
  15. Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2012 Feb; 53(2):959-66.
    View in: PubMed
    Score: 0.016
  16. The role of liver stromal cells in dendritic cells development in mice. Transplant Proc. 2010 Dec; 42(10):4279-81.
    View in: PubMed
    Score: 0.015
  17. Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis. Immunobiology. 2011 Apr; 216(4):528-34.
    View in: PubMed
    Score: 0.015
  18. A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection. Microsurgery. 2010 May; 30(4):332-7.
    View in: PubMed
    Score: 0.014
  19. Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. J Hepatol. 2009 Sep; 51(3):510-9.
    View in: PubMed
    Score: 0.014
  20. Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation. 2008 Dec 15; 86(11):1492-502.
    View in: PubMed
    Score: 0.013
  21. ICAM-1 expressed on hepatic stellate cells plays an important role in immune regulation. Microsurgery. 2007; 27(4):328-32.
    View in: PubMed
    Score: 0.011
  22. Cotransplanted hepatic stellate cells enhance vascularization of islet allografts. Microsurgery. 2007; 27(4):324-7.
    View in: PubMed
    Score: 0.011
  23. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology. 2006 Nov; 44(5):1171-81.
    View in: PubMed
    Score: 0.011
  24. Immune regulatory activity of liver-derived dendritic cells generated in vivo. Microsurgery. 2006; 26(1):17-20.
    View in: PubMed
    Score: 0.011
  25. Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization. J Cancer Res Clin Oncol. 2005 Jul; 131(7):429-38.
    View in: PubMed
    Score: 0.010
  26. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity. Ann Surg. 2005 Mar; 241(3):497-505.
    View in: PubMed
    Score: 0.010
  27. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology. 2004 Dec; 40(6):1312-21.
    View in: PubMed
    Score: 0.010
  28. Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway. J Immunol. 2004 Feb 01; 172(3):1355-63.
    View in: PubMed
    Score: 0.009
  29. Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58. Transpl Int. 2003 Dec; 16(12):849-56.
    View in: PubMed
    Score: 0.009
  30. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation. 2003 Aug 27; 76(4):721-9.
    View in: PubMed
    Score: 0.009
  31. Prolonged survival of heart allografts transduced with AAV-CTLA4Ig. Microsurgery. 2003; 23(5):489-93.
    View in: PubMed
    Score: 0.009
  32. Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity. Microsurgery. 2003; 23(5):494-7.
    View in: PubMed
    Score: 0.009
  33. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol. 2002 Sep 15; 169(6):3382-91.
    View in: PubMed
    Score: 0.008
  34. Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol. 2001 Jun 15; 166(12):7042-52.
    View in: PubMed
    Score: 0.008
  35. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance. J Immunol. 2001 May 01; 166(9):5619-28.
    View in: PubMed
    Score: 0.008
  36. Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts. Transplant Proc. 2001 Feb-Mar; 33(1-2):129-30.
    View in: PubMed
    Score: 0.008
  37. Presentation of MHC-disparate donor antigens predominantly by the indirect pathway results in the development of posttransplant vasculopathy: salutary effects of perioperative costimulatory blockade. Transplant Proc. 2001 Feb-Mar; 33(1-2):307.
    View in: PubMed
    Score: 0.008
  38. Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation. Transplant Proc. 2001 Feb-Mar; 33(1-2):382.
    View in: PubMed
    Score: 0.008
  39. Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model. Cell Transplant. 2001; 10(3):343-50.
    View in: PubMed
    Score: 0.008
  40. Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection. Immunology. 2000 Oct; 101(2):233-41.
    View in: PubMed
    Score: 0.007
  41. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol Ther. 2000 May; 1(5 Pt 1):430-7.
    View in: PubMed
    Score: 0.007
  42. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. Transplantation. 1999 Nov 15; 68(9):1402-9.
    View in: PubMed
    Score: 0.007
  43. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation. 1999 Sep 27; 68(6):747-57.
    View in: PubMed
    Score: 0.007
  44. Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection. Transplantation. 1999 May 27; 67(10):1295-300.
    View in: PubMed
    Score: 0.007
  45. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms. Transplantation. 1999 Feb 15; 67(3):444-50.
    View in: PubMed
    Score: 0.007
  46. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Transplantation. 1998 Dec 27; 66(12):1587-96.
    View in: PubMed
    Score: 0.007
  47. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation. 1998 Jun 27; 65(12):1590-8.
    View in: PubMed
    Score: 0.006
  48. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation. 1997 Dec 27; 64(12):1808-15.
    View in: PubMed
    Score: 0.006
  49. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation. 1997 Dec 27; 64(12):1838-43.
    View in: PubMed
    Score: 0.006
  50. Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. Transplantation. 1997 Sep 15; 64(5):690-5.
    View in: PubMed
    Score: 0.006
  51. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol. 1997 May 15; 158(10):4654-61.
    View in: PubMed
    Score: 0.006
  52. Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts. Transplant Proc. 1997 Feb-Mar; 29(1-2):1310.
    View in: PubMed
    Score: 0.006
  53. Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. Transplantation. 1996 Dec 27; 62(12):1709-14.
    View in: PubMed
    Score: 0.006
  54. Patterns of inflammatory vascular endothelial changes in murine liver grafts. Transplantation. 1995 Sep 27; 60(6):577-84.
    View in: PubMed
    Score: 0.005
  55. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med. 1995 Aug 01; 182(2):379-87.
    View in: PubMed
    Score: 0.005
  56. In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation. Transplantation. 1995 Feb 27; 59(4):544-51.
    View in: PubMed
    Score: 0.005
  57. Propagation of cells expressing donor phenotype (MHC class I, II and Y-chromosome) from the bone marrow of murine liver allograft recipients in response to GM-CSF in vitro. Transplant Proc. 1995 Feb; 27(1):191-3.
    View in: PubMed
    Score: 0.005
  58. Suppression of alloreactive T-cell activation by murine liver F4/80+ accessory cells and kinetics of intrahepatic F4/80+ cells following liver transplantation. Transplant Proc. 1995 Feb; 27(1):520-1.
    View in: PubMed
    Score: 0.005
  59. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation. 1994 Jul 15; 58(1):1-8.
    View in: PubMed
    Score: 0.005
  60. Interferon-gamma induced expression of MHC antigens facilitates identification of donor cells in chimeric transplant recipients. Cell Transplant. 1994 Jul-Aug; 3(4):345-8.
    View in: PubMed
    Score: 0.005
  61. Evidence for early Th 2 T cell predominance in xenoreactivity. Transplantation. 1993 Oct; 56(4):905-11.
    View in: PubMed
    Score: 0.005
  62. Xenoreactivity in mouse + rat-->mouse chimeras. Transplant Proc. 1993 Feb; 25(1 Pt 1):455-6.
    View in: PubMed
    Score: 0.004
  63. Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine. Transplant Proc. 1993 Feb; 25(1 Pt 1):704-5.
    View in: PubMed
    Score: 0.004
  64. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. Transplant Proc. 1991 Dec; 23(6):2957-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.